Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year
  1. Home
  2. Recombinant Proteins
  3. Recombinant Staphylokinase

Recombinant Staphylokinase

DESCRIPTION CATALOG # SIZE PRICE
Recombinant Staphylokinase CRP08119 1mg Please Inquiry
Product Detail
Cat
CRP08119
Product Overview
Recombinant Staphylokinase produced in E.coli is a single non-glycosylated polypeptide chain containing 136 amino acids and having a molecular mass of approximately 16 kDa.
Specificity
Fully biologically active when compared to standard. The specific biological activity measured by the ability of fibrin lysis in agarose plate was found to be 50000U/mg.
Endotoxin
Less than 1EU/mg of rSAK as determined by LAL method.
Purity
>95% by SDS-PAGE and HPLC analyses.
Storage
This lyophilized preparation is stable for several weeks at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at <-20°C. Further dilutions should be made in appropriate buffered solutions.
Background
Antigen Description
Staphylokinase (SAK), a 16kDa profibrinolytic protein from the Staphylococcus aureus, has been demonstrated to induce highly fibrin-specific thrombolysis in both human plasma and in limited clinical trials. It is positively regulated by the "agr" gene regulator. It activates plasminogen to form plasmin, which digest fibrin clots. This disrupts the fibrin meshwork which can often form to keep an infection localized.Recent studies on the thrombolytic potential of recombinant SAK in achieving early perfusion in myocardial infarction and in the dissolution of platelet-rich clot have clearly established its immense utility in clinical medicine as a thrombolytic agent and suggested that it can be developed as a potent clot-dissolving agent.
Download Datasheet:
Related Products
CRP0890
Recombinant Human Bone Morphogenetic Protein-7
CRP08106
Recombinant Human Macrophage Inflammatory Protein 4 /CCL18
CRP0893
Recombinant Human Oncostatin M
CRP0870
Recombinant Human Pigment Epithelium-derived Factor
CRP0854
Recombinant Human C-Fragment of Nonmuscle Myosin Heavy Chain 9, His tagged
CRP0871
Recombinant Bovine Fibroblast Growth Factor-basic
CRP0878
Recombinant Human Interleukin-1 alpha
CRP08113
Recombinant Human Interferon-inducible T-cell alpha chemoattractant /CXCL11
CRP08131
Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A
CRP0884
Recombinant Human soluble CD40 Ligand

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


Products

Antibody & Peptide Libraries Recombinant Antibodies Protein A Scaffold Chimeric Antigen Receptor (CAR) Products Antibody-Drug Conjugates (ADCs) Products

Services

Phage Display Libraries and Antibody Libraries Antibody Engineering De Novo Antibody Sequencing Services High-Affi™ Human Antibody Discovery Native™ Antibody Discovery Service Magic™ Membrane Protein Antibodies Membrane Protein Production Service

Technical Platforms

Phage Display Platform Protein Engineering Platform Membrane Protein Platform Hybridoma Platform

TOP
© 2007 - 2018 Creative-Biolabs All Rights Reserved